Novel MEMS technology for biomarker screening

点击翻译按钮获取中文摘要

There is tremendous pressure on the health system to rapidly, and accurately detect diseases as early as possible. Many diseases, such as neurodegenerative diseases and cancer lack early detection markers. It is clear that the identification of diseases for which there are known diagnostic approaches has had issues in accuracy, such as the recent reports of breast cancer miss-diagnosis. Addressing these issues will require panels of biomarkers that can provide early detection of diseases and which enhance the accuracy of the diagnosis. There are currently many efforts in genomics and proteomics to discover novel candidate biomarkers with a particular focus on panels of biomarkers. Very little efforts have been focused on how these panels of biomarkers will be translated to the clinic. In recent years, mass spectrometry based proteomic